Sue-jean Lin, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 4,946 shares at $24.38 ($121K) on 2026-06-15, disclosed to the SEC on 2026-06-17.
Scheduled sale ($121k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.